• Users Online: 257
  • Print this page
  • Email this page
Year : 2021  |  Volume : 10  |  Issue : 6  |  Page : 221-226

Manifestations and risk factors of COVID-19 and mucormycosis: A mini-review

1 Institute of Pharmacy, Harishchandra PG College, Bawan Beegha, Varanasi 221002, India
2 Department of Pharmaceutical Technology, University of North Bengal, Raja Rammohunpur, Darjeeling, West Bengal 734013, India

Correspondence Address:
Jugal Sutradhar
Institute of Pharmacy, Harishchandra PG College, Bawan Beegha, Varanasi 221002
Login to access the Email id

Source of Support: None, Conflict of Interest: None

DOI: 10.4103/2221-6189.330739

Rights and Permissions

Coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 has become a pandemic disease. It also increases the risk of co-infections. Mucormycosis is a severe fungal infectious disease and its causative agent, mucormycetes, belongs to an opportunist fungus Mucoraceae family. Mucormycosis in COVID-19 patients with mucormycosis presents an additional challenge worldwide. Mucormycosis shares certain risk factors and signs and symptoms with COVID-19. In this review, we summarize manifestations and risk factors of mucormycosis and COVID-19.

Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)

 Article Access Statistics
    PDF Downloaded211    
    Comments [Add]    

Recommend this journal